Lopukhova, Ekaterina A.,
Ibragimova, Rada R.,
Idrisova, Gulnaz M.,
Lakman, Irina A.,
Mukhamadeev, Timur R.,
Grakhova, Elizaveta P.,
Bilyalov, Azat R.,
Kutluyarov, Ruslan V. (2023) their
effectiveness, sources of input information, and work verification. This statistical review analyzes examples
Sharipov, R.A.,
Omarov, M.A.,
Mulyukov, A.R.,
Dybova, A.I.,
Vyaseleva, E.T.,
Kayumova, N.B.,
Saitgalina, A. Sh.,
Ententeev, K.R.,
Iagafarov, I.R.,
Kuserbaev, I.V.,
Gubaeva, E.A. (2023) of the CRISPR/Cas9 technology and achieve the desired therapeutic
effect. © 2023, Allerton Press, Inc.
Mukhtarova, Liliya A.,
Fedorova, Yulia Yu.,
Karunas, Aleksandra S.,
Prokofyeva, Darya S.,
Nurgalieva, Alfia Kh.,
Khusnutdinova, Elza K.,
Zagidullin, Shamil Z. (2023) . Insufficiently
effective control of BA leads to a reduction in the quality of life, the development of its more
Gareev, Ilgiz,
Beylerli, Ozal,
Tamrazov, Rasim,
Ilyasova, Tatiana,
Shumadalova, Alina,
Du, Weijie,
Yang, Baofeng (2023) effectively target various structures within the central nervous system (CNS). MiRNA-based therapy stands out
Beylerli, Ozal,
Tamrazov, Rasim,
Gareev, Ilgiz,
Ilyasova, Tatiana,
Shumadalova, Alina,
Bai, Yunlong,
Yang, Baofeng (2023) in understanding the pathophysiology of TBI,
effective treatments remain limited. In recent years, exosomal non